Risk factors for West Nile virus infection and disease in populations and individuals

Expert Review of Anti-Infective Therapy

Volumn 13, Issue 3, 2015, Pages 317-325

  Montgomery, Ruth R ^a   Murray, Kristy O ^b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b TEXAS CHILDREN S HOSPITAL   (United States)

Author keywords

aging; avian reservoir; epizootic spread; immune response; mosquito vector; mouse model; West Nile virus

Indexed keywords

ALPHA INTERFERON; CHEMOKINE; CYTOKINE; RIBAVIRIN; VIRUS PROTEIN; WEST NILE VACCINE; BIOLOGICAL MARKER;

AGING; ARTICLE; BIRD; BLOOD BRAIN BARRIER; CLIMATE; CLINICAL FEATURE; DISEASE CARRIER; DISEASE PREDISPOSITION; DISEASE SEVERITY; FLAVIVIRUS INFECTION; GENETIC MARKER; HUMAN; HYPERTENSION; IMMUNE DEFICIENCY; IMMUNE RESPONSE; MOSQUITO; NONHUMAN; NORTH AMERICA; POPULATION ABUNDANCE; RISK FACTOR; SPECIES HABITAT; T LYMPHOCYTE; VACCINATION; VIRUS TRANSMISSION; WEST NILE FLAVIVIRUS; WEST NILE FLAVIVIRUS INFECTION; ADAPTIVE IMMUNITY; ANIMAL; CANADA; CARIBBEAN; EPIDEMIOLOGY; GENETICS; IMMUNOLOGY; INNATE IMMUNITY; MEXICO; TRANSMISSION; UNITED STATES; VIROLOGY; WEST NILE FEVER; WEST NILE VIRUS;

ADAPTIVE IMMUNITY; AGING; ANIMALS; BIOLOGICAL MARKERS; BIRDS; CANADA; CARIBBEAN REGION; CULICIDAE; HUMANS; IMMUNITY, INNATE; MEXICO; RISK FACTORS; UNITED STATES; WEST NILE FEVER; WEST NILE VIRUS;

EID: 84923050029     PISSN: 14787210     EISSN: 17448336     Source Type: Journal    
DOI: 10.1586/14787210.2015.1007043     Document Type: Article

References (120)

1. Petersen LR, Carson PJ, Biggerstaff BJ, et al. Estimated cumulative incidence of West Nile virus infection in US adults, 1999-2010. Epidemiol. Infect. 2013;141:591-5
2. Lindsey NP, Lehman JA, Hayes EB, et al. West Nile Virus Activity- United States, 2006. JAMA 2007;298:619-21
3. Gubler DJ. The continuing spread of West Nile virus in the western hemisphere. Clin Infect Dis 2007;45:1039-46
4. Arjona A, Wang P, Montgomery RR, Fikrig E. Innate Immune Control of West Nile Virus Infection. Cell Microbiol 2011;13:1648-58
5. Colpitts TM, Conway MJ, Montgomery RR, Fikrig E. West Nile Virus: biology, Transmission and Human Infection. Clin Microbiol Rev 2012;25:635-48
6. Petersen LR, Marfin AA. West Nile virus: a primer for the clinician. Ann Intern Med 2002;137:173-9
7. Diamond MS. Development of effective therapies against West Nile virus infection. Expert Rev Anti Infect Ther 2005;3:931-44
8. Nash D, Mostashari F, Fine A, et al. The outbreak of West Nile virus infection in the New York City area in. 1999;N Engl J Med 2001;344:1807-14
9. Steele KE, Linn MJ, Schoepp RJ, et al. Pathology of fatal West Nile virus infections in native and exotic birds during the 1999 outbreak in New York City, New York. Vet Pathol 2000;37:208-24
10. Trock SC, Meade BJ, Glaser AL, et al. West Nile virus outbreak among horses in New York State, 1999 and 2000. Emerg Infect Dis 2001;7:745-7
11. Davis CT, Ebel GD, Lanciotti RS, et al. Phylogenetic analysis of North American West Nile virus isolates, 2001-2004: evidence for the emergence of a dominant genotype. Virology 2005;342:252-65
12. Brackney DE, Beane JE, Ebel GD. RNAi targeting of West Nile virus in mosquito midguts promotes virus diversification. PLoS Pathog 2009;5:e1000502
13. ArboNET. West Nile Virus Statistics and Maps. C. f. D. C. a. Prevention, ed. National Center for Emerging and Zoonotic Infectious Diseases (NCEZID) Division of Vector-Borne Diseases (DVBD). 2014
14. MMWR. Update: Investigations of West Nile virus infections in recipients of organ transplantation and blood transfusion -Michigan, 2002. MMWR Morb Mortal Wkly Rep 2002;51:879
15. MMWR. Possible West Nile virus transmission to an infant through breast-feeding - Michigan, 2002. MMWR Morb Mortal Wkly Rep 2002;51:877-8
16. MMWR. Intrauterine West Nile virus infection - New York, 2002. MMWR Morb Mortal Wkly Rep 2002;51:1135-6
17. Zou S, Foster GA, Dodd RY, et al. West Nile fever characteristics among viremic persons identified through blood donor screening. J Infect Dis 2010;202:1354-61
18. Lanteri MC, Lee TH, Wen L, et al. West Nile virus nucleic acid persistence in whole blood months after clearance in plasma: implication for transfusion and transplantation safety. Transfusion 2014;54:3232-41
19. Basavaraju SV, Kuehnert MJ, Zaki SR, et al. Encephalitis caused by pathogens transmitted through organ transplants, United States, 2002-2013. Emerg Infect Dis 2014;20:1443-51
20. Bradford CM, Nascarella MA, Burns TH, et al. First report of West Nile virus in mosquitoes from Lubbock County, Texas. J Am Mosq Control Assoc 2005;21:102-5
21. Murray KO, Ruktanonchai D, Hesalroad D, et al. West Nile virus, Texas, USA, 2012 Emerg Infect Dis;2013;19:1836-8
22. Paz S, Semenza JC. Environmental drivers of West Nile fever epidemiology in Europe and Western Asia - a review. Int J Environ Res Public Health 2013;10:3543-62
23. Kunkel KE, Novak RJ, Lampman RL, Gu W. Modeling the impact of variable climatic factors on the crossover of Culex restauns and Culex pipiens (Diptera: culicidae), vectors of West Nile virus in Illinois. Am J Trop Med Hyg 2006;74:168-73
24. Dohm DJ, O'Guinn ML, Turell MJ. Effect of environmental temperature on the ability of Culex pipiens (Diptera: culicidae) to transmit West Nile virus. J Med Entomol 2002;39:221-5
25. Reisen WK. Effect of temperature on Culex tarsalis (Diptera: culicidae) from the Coachella and San Joaquin Valleys of California. J Med Entomol 1995;32:636-45
26. Ruiz MO, Chaves LF, Hamer GL, et al. Local impact of temperature and precipitation on West Nile virus infection in Culex species mosquitoes in northeast Illinois. USA. Parasit Vectors 2010;3:19
27. Manore CA, Davis J, Christofferson RC, et al. Towards an early warning system for forecasting human west nile virus incidence. PLoS Curr 2014;6
28. Paz S, Albersheim I. Influence of warming tendency on Culex pipiens population abundance and on the probability of West Nile fever outbreaks (Israeli Case Study. 2001. Ecohealth 2008;5:40-8
29. Kilpatrick AM, Meola MA, Moudy RM, Kramer LD. Temperature, viral genetics, and the transmission of West Nile virus by Culex pipiens mosquitoes. PLoS Pathog 2008;4:e1000092
30. Pawelek KA, Niehaus P, Salmeron C, et al. Modeling Dynamics of Culex pipiens Complex Populations and Assessing Abatement Strategies for West Nile Virus. PLoS One 2014;9:e108452
31. Takeda T, Whitehouse CA, Brewer M, et al. Arbovirus surveillance in Rhode Island: assessing potential ecologic and climatic correlates. J Am Mosq Control Assoc 2003;19:179-89
32. Koenraadt CJ, Harrington LC. Flushing effect of rain on container-inhabiting mosquitoes Aedes aegypti and Culex pipiens (Diptera: culicidae). J Med Entomol 2008;45:28-35
33. Roehr B. US hit by massive West Nile virus outbreak centred around Texas. BMJ 2012;345:e5633
34. Nolan MS, Zangeneh A, Khuwaja SA, et al. Proximity of residence to bodies of water and risk for west nile virus infection: a case-control study in Houston. Texas. J Biomed Biotechnol 2012;2012:159578
35. Cardenas VM, Jaime J, Ford PB, et al. Yard flooding by irrigation canals increased the risk of West Nile disease in El Paso. Texas. Ann Epidemiol 2011;21:922-9
36. Schurich JA, Kumar S, Eisen L, Moore CG. Modeling Culex tarsalis abundance on the northern Colorado front range using a landscape-level approach. J Am Mosq Control Assoc 2014;30:7-20
37. Meyer TE, Bull LM, Cain Holmes K, et al. West Nile virus infection among the homeless, Houston, Texas. Emerg Infect Dis 2007;13:1500-3
38. Mostashari F, Bunning ML, Kitsutani PT, et al. Epidemic West Nile encephalitis, New York, 1999: results of a household-based seroepidemiological survey. Lancet 2001 358:261-4
39. Murphy TD, Grandpre J, Novick SL, et al. West Nile virus infection among health-fair participants, Wyoming 2003: assessment of symptoms and risk factors. Vector Borne Zoonotic Dis 2005;5:246-51
40. Gujral IB, Zielinski-Gutierrez EC, LeBailly A, Nasci R. Behavioral risks for West Nile virus disease. northern Colorado 2003;Emerg Infect Dis 2007;13:419-25
41. Mandalakas AM, Kippes C, Sedransk J, et al. West Nile virus epidemic. northeast Ohio 2002;Emerg Infect Dis 2005;11:1774-7
42. Reisen WK, Fang Y, Martinez VM. Avian host and mosquito (Diptera: culicidae) vector competence determine the efficiency of West Nile and St. Louis encephalitis virus transmission. J Med Entomol 2005;42:367-75
43. Rappole JH, Derrickson SR, Hubalek Z. Migratory birds and spread of West Nile virus in the Western Hemisphere. Emerg Infect Dis 2000;6:319-28
44. Gomes B, Sousa CA, Vicente JL, et al. Feeding patterns of molestus and pipiens forms of Culex pipiens (Diptera: culicidae) in a region of high hybridization. Parasit Vectors 2013;6:93
45. Hamer GL, Kitron UD, Goldberg TL, et al. Host selection by Culex pipiens mosquitoes and West Nile virus amplification. Am J Trop Med Hyg 2009;80:268-78
46. Komar N, Langevin S, Hinten S, et al. Experimental infection of North American birds with the New York 1999 strain of West Nile virus. Emerg Infect Dis 2003;9:311-22
47. Kilpatrick AM, Kramer LD, Jones MJ, et al. West Nile virus epidemics in North America are driven by shifts in mosquito feeding behavior. PLoS Biol 2006;4:e82
48. Thiemann TC, Lemenager DA, Kluh S, et al. Spatial variation in host feeding patterns of Culex tarsalis and the Culex pipiens complex (Diptera: culicidae) in California. J Med Entomol 2012;49:903-16
49. Molaei G, Andreadis TG, Armstrong PM, et al. Host feeding pattern of Culex quinquefasciatus (Diptera: culicidae) and its role in transmission of West Nile virus in Harris County. Texas. Am J Trop Med Hyg 2007;77:73-81
50. Gray TJ, Webb CE. A review of the epidemiological and clinical aspects of West Nile virus. Int J Gen Med 2014;7:193-203
51. Guth JC, Futterer SA, Hijaz TA, et al. Pearls & oy-sters: bilateral thalamic involvement in West Nile virus encephalitis. Neurology 2014;83:e16-17
52. Murray K, Baraniuk S, Resnick M, et al. Risk factors for encephalitis and death from West Nile virus infection. Epidemiol Infect 2006;134:1325-32
53. Sejvar JJ, Lindsey NP, Campbell GL. Primary causes of death in reported cases of fatal West Nile Fever, United States, 2002-2006. Vector Borne Zoonotic Dis 2011;11:161-4
54. Nakaya HI, Wrammert J, Lee EK, et al. Systems biology of vaccination for seasonal influenza in humans. Nat Immunol 2011;12:786-95
55. Li S, Rouphael N, Duraisingham S, et al. Molecular signatures of antibody responses derived from a systems biology study of five human vaccines. Nat Immunol 2014;15:195-204
56. Lanteri MC, Kaidarova Z, Peterson T, et al. Association between HLA class I and class II alleles and the outcome of West Nile virus infection: an exploratory study. PLoS One 2011;6:e22948
57. Lim JK, Lisco A, McDermott DH, et al. Genetic variation in OAS1 is a risk factor for initial infection with West Nile virus in man. PLoS Pathog 2009;5:e1000321
58. Bigham AW, Buckingham KJ, Husain S, et al. Host genetic risk factors for West Nile virus infection and disease progression. PLoS One 2011;6:e24745
59. Yakub I, Lillibridge KM, Moran A, et al. Single nucleotide polymorphisms in genes for 2'-5'-oligoadenylate synthetase and RNase L inpatients hospitalized with West Nile virus infection. J Infect Dis 2005;192:1741-8
60. Loeb M, Eskandarian S, Rupp M. Genetic variants and susceptibility to neurological complications following West Nile virus infection. J Infect Dis 2011;204:1031-7
61. Lim JK, McDermott DH, Lisco A, et al. CCR5 deficiency is a risk factor for early clinical manifestations of West Nile virus infection but not for viral transmission. J Infect Dis 2010;201:178-85
62. Ruan Q, Qian F, Yu Z. Effects of polymorphisms in immunity-related genes on the immune system and successful aging. Curr Opin Immunol 2014;29:49-55
63. Shaw AC, Goldstein DG, Montgomery RR. Dysregulated innate immune function in aging. Nat Rev Immunol 2013;13:875-87
64. Kong K-F, Delroux K, Wang X, et al. Dysregulation of TLR3 impairs the innate immune response to West Nile virus in the elderly. J Virol 2008;82:7613-23
65. Qian F, Wang X, Zhang l, et al. Impaired interferon signaling in dendritic cells from older donors infected in vitro with West Nile virus. J Infect Dis 2011;203:1415-24
66. Kramer LD, Bernard KA. West Nile virus infection in birds and mammals. Ann NY Acad Sci 2001;951:84-93
67. Ben-Nathan D, Huitinga I, Lustig S, et al. West Nile virus neuroinvasion and encephalitis induced by macrophage depletion in mice. Arch Virol 1996;141:459-69
68. Bai F, Kong K-F, Dai J, et al. A paradoxical role for neutrophils in the pathogenesis of West Nile virus. J Infect Dis 2010;202:1804-12
69. Wang T, Scully E, Yin Z, et al. IFN-g-producing gd T cells help control murine West Nile virus infection. J Immunol 2003;171:2524-31
70. Qian F, Goel G, Meng H. Systems Immunology reveals markers of susceptibility to West Nile virus infection. Clin Vacc Immunol 2015;22:6-16
71. Tobler LH, Cameron MJ, et al. Interferon and interferon-induced chemokine expression is associated with control of acute viremia in West Nile virus-infected blood donors. J Infect Dis 2008;198:979-83
72. Thackray LB, Shrestha B, Richner JM, et al. Interferon Regulatory Factor 5-Dependent Immune Responses in the Draining Lymph Node Protect against West Nile Virus Infection. J Virol 2014;88:11007-21
73. Errett JS, Suthar MS, McMillan A, et al. The essential, nonredundant roles of RIG-I and MDA5 in detecting and controlling West Nile virus infection. J Virol 2013;87:11416-25
74. Suthar MS, Pulendran B. Systems analysis of West Nile virus infection. Curr Opin Virol 2014;6:70-5
75. Brass AL, Benita Y, John SP, et al. The IFITM proteins mediate cellular resistance to influenza A H1N1 virus, West Nile virus, and dengue virus. Cell 2009;139:1243-54
76. Wang P, Yang L, Cheng G, et al. UBXN1 interferes with RLR-mediated antiviral immune response by targeting MAVS. Cell Reports 2013;4:1057-70
77. Cho H, Diamond MS. Immune responses to West Nile virus infection in the central nervous system. Viruses 2012;4:3812-30
78. Wang T, Town T, Alexoupoulou L, et al. Toll-like receptor 3 mediates West Nile virus entry into the brain causing lethal encephalitis. Nat Med 2004;10:1366-73
79. Wang P, Dai J, Bai F, et al. Matrix metalloproteinase 9 facilitates West Nile Virus entry into the brain. J. Virol 2008;82:8978-85
80. Wang P, Arjona A, Zhang Y, et al. Caspase-12 controls West Nile virus infection via the viral RNA receptor RIG-I. Nat Immunol 2010;11:912-19
81. Arjona A, Foellmer H, Town T, et al. Abrogation of Macrophage Migration Inhibitory Factor Decreases West Nile Virus Lethality by Limiting Viral Neuroinvasion. J Clin Invest 2007;117:3059-66
82. Dai J, Wang P, Bai F, et al. ICAM-1 participates in the entry of West Nile virus into the central nervous system. J Virol 2008;82:4164-8
83. Town T, Bai F, Wang T, et al. Tlr7 mitigates lethal West Nile encephalitis by affecting interleukin 23-dependent immune cell infiltration and homing. Immunity 2009;30:242-53
84. Wang S, Welte T, McGargill M, et al. Drak2 contributes to West Nile virus entry into the brain and lethal encephalitis. J Immunol 2008;181:2084-91
85. Wang P, Bai F, Zenewicz LA, et al. IL-22 signaling contributes to West Nile virus encephalitis pathogenesis. PLoS One 2012;7:e44153
86. Shrestha B, Zhang B, Purtha WE, et al. Tumor necrosis factor alpha protects against lethal West Nile virus infection by promoting trafficking of mononuclear leukocytes into the central nervous system. J Virol 2008;82:8956-64
87. Klein RS, Lin E, Zhang B, et al. Neuronal CXCL10 directs CD8+ T-cell recruitment and control of West Nile virus encephalitis. J Virol 2005;79:11457-66
88. Zhang B, Chan YK, Lu B, et al. CXCR3 mediates region-specific antiviral T cell trafficking within the central nervous system during West Nile virus encephalitis. J Immunol 2008;180:2641-9
89. King NJ, Getts DR, Getts MT, et al. Immunopathology of flavivirus infections. Immunol Cell Biol 2007;85:33-42
90. Lim JK, Obara CJ, Rivollier A, et al. Chemokine receptor Ccr2 is critical for monocyte accumulation and survival in West Nile virus encephalitis. J Immunol 2011;186:471-8
91. Ramos HJ, Lanteri MC, Blahnik G, et al. IL-1beta signaling promotes CNS-intrinsic immune control of West Nile virus infection. PLoS Pathog 2012;8:e1003039
92. Durrant DM, Robinette ML, Klein RS. IL-1R1 is required for dendritic cell-mediated T cell reactivation within the CNS during West Nile virus encephalitis. J Exp Med 2013;210:503-16
93. Cho H, Shrestha B, Sen GC, Diamond MS. A role for Ifit2 in restricting West Nile virus infection in the brain. J Virol 2013;87:8363-71
94. Tyler KL, Pape J, Goody RJ, et al. CSF findings in 250 patients with serologically confirmed West Nile virus meningitis and encephalitis. Neurology 2006;66:361-5
95. Lazear HM, Pinto AK, Ramos HJ. Pattern recognition receptor MDA5 modulates CD8 + T cell-dependent clearance of West Nile virus from the central nervous system. J Virol 2013;87:11401-15
96. Lanteri MC, Heitman JW, Owen RE, et al. Comprehensive analysis of west nile virus-specific T cell responses in humans. J Infect Dis 2008;197:1296-306
97. Parsons R, Lelic A, Hayes L, et al. The memory T cell response to West Nile virus in symptomatic humans following natural infection is not influenced by age and is dominated by a restricted set of CD8+ T cell epitopes. J Immunol 2008;181:1563-72
98. Chou C, Pinto AK, Curtis JD, et al. c-Myc-induced transcription factor AP4 is required for host protection mediated by CD8(+) T cells. Nat Immunol 2014;15:884-93
99. Shrestha B, Diamond MS. Role of CD8+ T cells in control of West Nile virus infection. J Virol 2004;78:8312-21
100. Brien JD, Uhrlaub JL, Nikolich-Zugich J. West Nile virus-specific CD4 T cells exhibit direct antiviral cytokine secretion and cytotoxicity and are sufficient for antiviral protection. J Immunol 2008;181:8568-75
101. Piazza P, McMurtrey CP, Lelic A, et al. Surface phenotype and functionality of WNV specific T cells differ with age and disease severity. PLoS One 2010;5:e15343
102. Lanteri MC, O'Brien KM, Purtha WE, et al. Tregs control the development of symptomatic West Nile virus infection in humans and mice. J Clin Invest 2009;119:3266-77
103. Lanteri MC, Diamond MS, Law JP, et al. Increased frequency of Tim-3 expressing T cells is associated with symptomatic West Nile virus infection. PLoS One 2014;9: e92134
104. Diamond MS, Shrestha B, Marri A, et al. B cells and antibody play critical roles in the immediate defense of disseminated infection by West Nile encephalitis virus. J Virol 2003;77:2578-86
105. Busch MP, Kleinman SH, Tobler LH, et al. Virus and antibody dynamics in acute west nile virus infection. J Infect Dis 2008;198:984-93
106. Prince HE, Lape-Nixon M, Yeh C, et al. Persistence of antibodies to West Nile virus nonstructural protein 5. J Clin Virol 2008;43:102-6
107. Qian F, Thakar J, Yuan X, et al. Immune markers associated with host susceptibility to infection with West Nile virus. Viral Immunology 2014;27:39-47
108. Amanna IJ, Carlson NE, Slifka MK. Duration of humoral immunity to common viral and vaccine antigens. N Engl J Med 2007;357:1903-15
109. You F, Wang P, Yang L, et al. ELF4 is critical for induction of type I interferon and the host antiviral response. Nat Immunol 2013;14:1237-46
110. Wang T, Anderson JF, Magnarelli LA, et al. Immunization of mice against West Nile virus with recombinant envelope protein. J Immunol 2001;167:5273-7
111. Ben-Nathan D, Lustig S, Tam G, et al. Prophylactic and therapeutic efficacy of human intravenous immunoglobulin in treating West Nile virus infection in mice. J Infect Dis 2003;188:5-12 112j06-13
112. Oliphant T, Engle M, Nybakken GE, et al. Development of a humanized monoclonal antibody with therapeutic potential against West Nile virus. Nat Med 2005;11:522-30
113. Sultana H, Foellmer HG, Neelakanta G, et al. Fusion loop peptide of the West Nile virus envelope protein is essential for pathogenesis and is recognized by a therapeutic cross-reactive human monoclonal antibody. J Immunol 2009;183:650-60
114. Demento SL, Bonafe N, Cui W, et al. TLR9-targeted biodegradable nanoparticles as immunization vectors protect against West Nile encephalitis. J Immunol 2010;185:2989-97
115. Pinto AK, Richner JM, Poore EA, et al. A hydrogen peroxide-inactivated virus vaccine elicits humoral and cellular immunity and protects against lethal West Nile virus infection in aged mice. J Virol 2013;87:1926-36
116. Lai H, He J, Hurtado J, et al. Structural and functional characterization of an anti-West Nile virus monoclonal antibody and its single-chain variant produced in glycoengineered plants. Plant Biotechnol J 2014;12:1098-107
117. Gardner IA, Wong SJ, Ferraro GL, et al. Incidence and effects of West Nile virus infection in vaccinated and unvaccinated horses in California. Vet Res 2007;38:109-16
118. Seino KK, Long MT, Gibbs EP, et al. Comparative efficacies of three commercially available vaccines against West Nile Virus (WNV) in a short-duration challenge trial involving an equine WNV encephalitis model. Clin Vaccine Immunol 2007;14:1465-71
119. Beigel JH, Nordstrom JL, Pillemer SR, et al. Safety and pharmacokinetics of single intravenous dose of MGAWN1, a novel monoclonal antibody to West Nile virus. Antimicrob Agents Chemother 2010;54:2431-6
120. Daffis S, Suthar MS, Szretter KJ, et al. Induction of IFN-beta and the innate antiviral response in myeloid cells occurs through an IPS-1-dependent signal that does not require IRF-3 and IRF-7. PLoS Pathog 2009;5:e1000607